Filing Details
- Accession Number:
- 0001437749-24-020547
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-17 18:08:20
- Reporting Period:
- 2024-06-13
- Accepted Time:
- 2024-06-17 18:08:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645469 | Monopar Therapeutics | MNPR | Pharmaceutical Preparations (2834) | 320463781 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1863624 | Andrew Cittadine | 1000 Skokie Blvd Suite 350 Wilmette IL 60091 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-13 | 12,000 | $0.91 | 129,624 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-06-14 | 12,000 | $0.93 | 141,624 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-06-17 | 12,000 | $0.90 | 153,624 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9100 to $0.93994, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.
Billionaire Hedge Funds
